Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00212771
Status:
COMPLETED
Last Update Posted:
2022-02-16
First Post:
2005-09-13
Brief Title:
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder 25520P05846
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
Long-Term Efficacy and Safety Evaluation of Asenapine 10-20 mgDay in With Schizophrenia or Schizoaffective Disorder in a Multicenter Trial Using 10-20 mgDay as a Control
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ACTAMESA
Brief Summary:
The primary features of schizophrenia and schizoaffective disorder are positive inability to think clearly and distinguish reality from fantasy and negative symptoms reduction or absence of normal behavior or emotions Other symptoms include reduced ability to recall and learn information difficulty in problem solving maintaining productive employment
Asenapine is an investigational drug that may help to correct the above schizophrenia by altering the inbalance of brain hormones such as dopamine serotonin This is a long-term extension trial to further test the efficacy and safety asenapine and a comparator agent olanzapine in the treatment of patients with schizophrenia
Asenapine is an investigational drug that may help to correct the above schizophrenia by altering the inbalance of brain hormones such as dopamine serotonin This is a long-term extension trial to further test the efficacy and safety asenapine and a comparator agent olanzapine in the treatment of patients with schizophrenia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 25520 | None | None | None |